Cases & Deals

Celgene invests in Presage Biosciences

Clients Celgene Corporation

Jones Day represented Celgene Corporation, a biopharmaceutical company, in connection with its investment in Presage Biosciences, a company researching effective cancer drug combinations.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.